Risk of heavy menstrual bleeding following COVID-19 vaccination: A nationwide case-control study
These findings provide evidence of an increased risk of heavy menstrual bleeding during the three-month period following primary COVID-19 mRNA vaccination. No increased risk was found beyond 3 months after primary vaccination nor following booster doses.
Authors
- Marie-Joëlle Jabagi (ORCID: https://orcid.org/0000-0002-7946-7759)
- Jérôme Drouin (ORCID: https://orcid.org/0000-0003-2017-7041)
- Stéphane Le Vu (ORCID: https://orcid.org/0000-0002-1303-8281)
- Kim Bouillon (ORCID: https://orcid.org/0000-0002-8086-7987)
- Marion Bertrand (ORCID: https://orcid.org/0000-0002-4115-7093)
- Rosemary Dray‐Spira (ORCID: https://orcid.org/0000-0001-7646-3667)
- Laura Semenzato (ORCID: https://orcid.org/0000-0002-8305-3487)
- Mahmoud Zureik (ORCID: https://orcid.org/0000-0002-8393-4217)
- Lise Duranteau
- Jérémie Botton (ORCID: https://orcid.org/0000-0002-4814-6370)
- Alain Weill (ORCID: https://orcid.org/0000-0001-8687-9092)
Institutions
- Conservatoire National des Arts et Métiers (FR)
- Inserm (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris-Saclay (FR)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
- Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail (FR)
- Bicêtre Hospital (FR)
Publication Details
- Journal
- Vaccine
- Published
- 2024-09-02
- DOI
- https://doi.org/10.1016/j.vaccine.2024.126252
- Citations
- 2
- Primary Topic
- COVID-19 Impact on Reproduction
- Type
- article
- Field-Weighted Citation Impact
- 1.17